Clinical Trials List
Protocol Number202501384A0
Not yet recruiting
2026-08-01 - 2029-07-31
Phase II/III
-
Trial Applicant
-
Sponsor
-
Trial scale
Taiwan Single Center
-
Update
2026/08/01
Investigators and Locations
Co-Principal Investigator
- Kung-Chu Ho Division of Nuclear Medicine
- 林啟瑞 Division of Others
- Kun-Ju Lin Division of Nuclear Medicine
- 林威丞 Division of Others
- 林煥鈞 Division of Nuclear Medicine
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
150 participants
-
Global
150 participants
